Combining a PD-1 immune checkpoint inhibitor with standard chemotherapy improved quality of life for patients with advanced stomach cancer or esophageal cancer compared to chemotherapy alone, according to recent findings ...
Oct 12, 2023
0
1
According to a new systematic review article, radiofrequency ablation and complete endoscopic resection are equally effective in the short-term treatment of dysplastic Barrett's esophagus, but adverse event rates are higher ...
May 21, 2014
0
0
The transition from the esophagus to the stomach is a delicate region from a medical point of view, often associated with pathological disorders leading to cancer. An international research team has now gained new insights ...
Apr 11, 2024
0
12
Esophageal squamous cell carcinoma (ESCC), the major histological form of esophageal cancer, is the leading cause of cancer death worldwide. Scientists from the National University of Singapore (NUS) have discovered a biomarker, ...
Jan 6, 2014
0
0
(HealthDay)—People who smoke and drink are nearly twice as likely to develop esophageal cancer as those with only one of those unhealthy habits, a new study indicates.
Apr 25, 2014
0
0
The U.S. Food and Drug Administration has approved Takeda's Eohilia (budesonide oral suspension) as the first and only oral treatment for eosinophilic esophagitis (EoE).
Feb 19, 2024
0
1
African-American patients with esophageal cancer survive fewer months after diagnosis than white patients, but only if they also have low incomes, according to a new study from Duke Health researchers.
Jan 27, 2016
0
3
(HealthDay)—A systematic review and meta-analysis of observational studies shows that central adiposity, independent of body mass index (BMI), is associated with increased risk of esophageal inflammation, metaplasia, and ...
Nov 21, 2013
0
0
The U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Dupixent (dupilumab) to treat eosinophilic esophagitis patients 12 years and older.
May 26, 2022
0
0
Researchers at Moffitt Cancer Center in Tampa, Fla., have found – contrary to previous studies linking inferior outcomes in patients with gastrointestinal malignancies to higher body mass index (BMI) – that in their ...
Mar 28, 2012
0
0
